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The potential of ethosomes for delivering ketoprofen via skin was evaluated. The ethosomes were
prepared, optimized and characterized. Vesicular shape, size and entrapment efﬁciency were deter-
mined by transmission electron microscopy, dynamic light scattering and minicolumn centrifugation
technique, respectively. Vesicle sizes varied from 120.376.1 to 410.2721.8 nm depending on the
concentrations of soya phosphatidyl choline (SPC) and ethanol. Entrapment efﬁciency increased with
concentrations of SPC and ethanol. The formulations exhibited entrapment efﬁciencies of 42–78%.
In vitro release through cellophane membrane showed sustained release of drug from ethosomal
formulations in contrast to hydroalcoholic drug solution (HA), which released most of the drug within
2–3 h. In vitro drug permeation across human skin revealed improved drug permeation and higher
transdermal ﬂux with ethosomal formulations compared to hydroethanolic drug solution. Kinetics of
in vitro skin permeation showed zero order drug release from formulations. Based on in vitro
transdermal ﬂux, the estimated steady state in vivo plasma concentration from ethosomes attained
therapeutic drug levels whereas hydroalcoholic drug solution exhibited sub therapeutic drug concen-
tration with a patch size of 50 cm2. Skin permeation of ethosomal formulations assessed by confocal
microscopy revealed enhanced permeation of Rhodamine 123 loaded formulation in comparison to the
hydroalcoholic solution.
& 2011 Elsevier B.V. All rights reserved.1. Introduction
The need of transdermal drug delivery is felt on the short-
comings of other existing drug delivery systems. Transdermal drug
delivery is a noninvasive technique and can be exploited to
circumvent the variables, which could inﬂuence the oral absorp-
tion of drugs such as pH, food intake and gastrointestinal motility
[2,22,30]. The greatest challenge with transdermal drug delivery is
the barrier nature of skin that restricts the entry of most of the
drugs [5,24]. Several physical and chemical techniques have been
tried and tested to overcome the barrier of stratum corneum to
achieve higher transdermal permeability. These techniques
include iontophoresis, sonophoresis, use of microneedles, chemi-
cals, surfactants and lipid based systems [18,20,21,23,28,31]. Lipid
based systems offer excellent candidature for transdermal delivery
due to their biocompatibility and ease of mixing with the skin
lipids. There has been considerable interest on the use of lipo-
somes for transdermal drug delivery [11,19,29]. However conven-
tional liposomes do not offer much value as they cannot penetrate
into deeper layers of skin, but rather conﬁned to the upper layerll rights reserved.stratum corneum [13]. Continuous research with lipid based
system has resulted in the introduction of two novel carriers,
transfersomes and ethosomes. Transfersomes are deformable lipid
vesicles consisting of phospholipids and an edge activator which is
often a single chain surfactant molecule [6]. Ethosomes are an
interesting lipid based carrier ﬁrst reported by Touitou et al.
[34,35]. Basically ethosomes exhibit lipid bilayers like liposomes;
however they differ with liposomes in terms of composition.
Liposomes are composed of phosphatidyl choline and cholesterol
whereas ethosomes contain high concentration of ethanol in place
of cholesterol. Ethosomes are prepared by either conventional thin
ﬁlm hydration method or by addition of aqueous phase in a
controlled manner to the alcoholic solution of phosphatidyl cho-
line. The size of ethosomes varies from few nanometers to
micrometers depending on method of preparation and application
of techniques like sonication. The value of ethosomes lies in its
capability to increase the transdermal permeability of entrapped
entity in comparison to liposomes or solution of drug in mixture of
ethanol and water [10,16,35]. With ethosomes, the synergistic
effect of combination of phospholipid and higher concentration
of alcohol is suggested to be responsible for deeper penetration
of entrapped drug(s) through skin with consequent high trans-
dermal ﬂux in comparison to liposomes. The efﬁcacy of ethosomes
in increasing transdermal permeability of entrapped drug is
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have reported superiority of ethosomal formulation in increasing
the transdermal permeability of entrapped ketotifen in compar-
ison to transfersomes.
The aim of the present investigation is to assess the applic-
ability of ethosomes in delivering ketoprofen through the skin.
We hypothesize that similar to ketotifen, ethosomes may be a
suitable vehicle to ketoprofen as well. Ketoprofen is a non
steroidal anti-inﬂammatory drug and is a good candidate for
transdermal delivery owing to problems in delivery by other
routes. Attempts have been made to develop suitable system for
improved transdermal delivery of ketoprofen despite several
topical gels/patches already available in the market [6,7,32].
However transdermal delivery of ketoprofen is always challenged
by its poor transdermal permeability [27]. In the present work we
entrapped ketoprofen in the lipid bilayers of ethosomes and
evaluated the in vitro transdermal permeation and penetration
characteristics through skin. Fig. 1 shows the schematic repre-
sentation of proposed entrapment of ketoprofen inside hydro-
phobic core of lipid bilayers of phophatidyl choline. Ketoprofen
being a hydrophobic drug is expected to partition itself in the
hydrophobic region of ethosomes vesicles formed from amphi-
pathic lipid phosphatidyl choline.2. Materials and methods
2.1. Materials
Skin samples of an adult female were obtained, with patient
consent and ethics approval, after abdominal reduction surgery.Fig. 1. Entrapment of ketoprofen (C) in lipid bilayers of phosphatidyl choline (B).
Figure represents distribution of ketoprofen molecules (denoted by K) in hydro-
phobic region of model lipid vesicular carrier (A).
Table 1
Composition and permeation parameters of various formulations acros
Formulations Composition (%) Transdermal ﬂ
(mg/cm2/h)
SPC Alcohol
E1 1 20 173.6722.7
E2 1 30 190.4724.3
E3 1 40 207.1723.3
E4 2 20 165.7719.0
E5 2 30 185.8725.8
E6 2 40 194.4720.1
E7 3 20 181.7717.1
E8 3 30 184.4721.0
E9 3 40 192.5724.8
HA – – 94.6710.3This study was approved by the Institutional Review Board (IRB)
of Singapore General Hospital, Republic of Singapore (IRB Refer-
ence Number 196/2006). This IRB operates in accordance with the
International Conference on Harmonization/Singapore Guideline
for Good Clinical Practices, and with the applicable regulatory
requirements.
Soya phosphatidyl choline (S-75) was a gift from Lipoid
(Germany). Ketoprofen, antimycotic solution and Rhodamine
123 were obtained from SIGMA-Aldrich (Germany). All other
reagents used were at least of reagent grade and used as such
without further puriﬁcation. Water puriﬁed by Milli Q system was
used for experiments.2.2. Preparation of the vesicular system
Ethosomal vesicles were prepared by the method reported
elsewhere with some modiﬁcations [9]. SPC was dissolved along
with the drug in ethanol in a glass bottle. The bottle was sealed
and connected to a syringe pump with Teﬂon tubing. The solution
was stirred using a magnetic stirrer at 1500 rpm and Milli Q water
was added at a constant rate of 1 ml/min at room temperature
through a syringe pump. After addition of water stirring was
continued for additional 30 min. The optimization of formulations
was carried out by varying SPC and alcohol concentration from
1–3% and 20–40%, respectively. The composition of various
formulations is reported in Table 1.2.3. Characterization of formulations
2.3.1. Size analysis of vesicular systems
The mean size of ethosomal colloidal suspension was analyzed
by dynamic light scattering technique with a Zetasizer 3000 HSA
(Malvern Instruments, Malvern, UK). The sample was placed in
quartz cuvette and size measurements were carried out at a
scattering angle of 901. All observations were recorded in tripli-
cate for each formulation.2.3.2. Vesicle shape
Shape and morphology of the ethosome vesicles were investi-
gated using transmission electron microscopy. Formulation
diluted with water was adsorbed onto a grid with carbon-coated
formvar ﬁlm that was attached to a metal specimen grid. Excess
sample was blotted off and the grid was covered with a small drop
of staining solution (2% w/v uranyl acetate). It was left on the grid
for few minutes and excess solution was drained off. The grid was
allowed to dry thoroughly in air and sample was examined in the
transmission electron microscope (JEOL, JEM 2010F).s human skin after 24 h.
ux Diffusional
release
exponent
Enhancement
ratio
Pss (mg/ml)
1.06 1.83 1.2770.16
1.06 1.54 1.470.17
1.05 2.18 1.5270.17
1.03 1.75 1.2170.13
1.03 1.96 1.3670.19
1.01 2.05 1.4370.14
1.03 1.92 1.3370.12
1.01 1.94 1.3570.15
1.00 2.03 1.4170.18
– – 0.6970.07
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For determination of entrapment efﬁciency the vesicles were
separated from the unentrapped or free drug by Sephadex
G-25 minicolumn centrifugation method. For preparation of mini-
column, Sephadex G-25 (2 g) was suspended in 100 ml saline and
was kept overnight. Subsequently supernatant was decanted and
the swollen gel was poured in 1 ml syringe and centrifuged to get
packed column free from saline. Formulation was placed on the
top of Sephadex column, and the formulation free from unen-
trapped drug was collected from the bottom. Separated formula-
tion was lysed using 10% v/v Triton X-100 and drug content was
determined using HPLC method. The Sephadex column was
covered to minimize the evaporation of ethanol from the hydro-
alcoholic ethosomal formulation. However, there is no inﬂuence
of this small change in the composition of formulation on drug
entrapment efﬁciency. Actually the total amount of drug
entrapped in the vesicles would not change as the formulation
elutes through the column.
2.4. In vitro drug release through cellophane membrane
For the experiment, formulation (1 ml) was placed in the
cellophane membrane dialysis tubing (molecular weight cut off
12,000, Himedia Labs, India), both the ends of which were sealed
and suspended in a beaker having 100 ml PBS pH 7.4 at 3771 1C
[14]. The buffer in the beaker was stirred with a glass rod at 45 min
interval and samples were collected at 2, 4, 6, 8, 10, 12, 18 and 24 h
time intervals, replaced with equal quantity of fresh buffer and
analyzed for the amount of drug released using HPLC. Various
ethosomal formulations were evaluated for drug release and for
comparison, hydroalcoholic drug solution was also included.
2.5. In vitro permeation of drug through skin
In vitro permeation was determined using ﬂow through diffu-
sion cell system consisting of 16 channel peristaltic cassette
pump (Ismatech, Switzerland), a circulating water bath (Hakke,
Germany), a fraction collector (ISCO Retriever IV, US) and ﬂow
through diffusion cells, similar to the setup we reported earlier
[20]. Adult Chinese female skin was used for the experiment. For
the preparation of the epidermis for experiment, skin along with
epidermis was immersed in water at 60 1C for 2 min and epider-
mis was carefully peeled off and stored at 80 1C until use. Prior
to experiments, skin was thawed and hydrated with saline
solution containing 1% v/v antibiotic antimycotic solution. Epi-
dermis was mounted between the donor and receptor compart-
ments of ﬂow through cells and excess part of the skin was
trimmed off. Phosphate buffer solution containing 1% v/v anti-
mycotic solution was ﬁlled in the reservoir bottle. Receptor
solution was thoroughly degassed to prevent the formation of
bubbles beneath the epidermis. Formulation (1 ml) was placed in
the donor compartment and covered with paraﬁlm to prevent
contamination and evaporation. Ambient temperature of the cells
was maintained at 37 1C by circulating water bath. The receptor
solution was pumped by peristaltic cassette pump continuously
through the receptor compartment and drained into sample
collection test tubes located in the fraction collector. Samples
were collected at various time intervals and analyzed for amount
of ketoprofen using HPLC. The graph was plotted between
cumulative amount of drug permeated versus time and with the
slope of graph transdermal ﬂux (J) was calculated. Steady state
drug plasma concentration (Pss) in vivo through the skin can be
predicted using the following equation, if the drug were in a patch
with area (Ta) of 50 cm2 [1]:
Pss¼ J  Ta=Clpwhere Clp is the plasma clearance of drug, which is 6.8 L/h for
ketoprofen.
2.6. Confocal laser scanning microscopy
In order to check the penetration of ethosomes through skin,
confocal laser scanning microscopy was performed. For imaging
purpose, formulations were loaded with ﬂuorescent probe Rho-
damine 123 instead of ketoprofen. Skin sample was mounted
between the donor and receiver compartment of ﬂow through cell
and excess portion was trimmed off. One ml of either formulation
or hydroalcoholic probe solution was placed in the donor com-
partment and covered with paraﬁlm to prevent contamination
and evaporation. Temperature of the cells was maintained at
37 1C. Skin was removed after four hours and excess formulation
on its surface was washed with water and skin samples were
optically scanned at different increments through the Z-axis of a
confocal laser scanning microscope (Nikon A1R).
2.7. Analysis of ketoprofen
Quantitative analysis of ketoprofen was performed by high
performance liquid chromatography system (LC 2010A, Shimadzu)
consisting of a pump, an automatic injector and an ultraviolet
detector. The stationary phase used in the analysis was C18 column
(Agilent, 5 mm, 4.0250 mm) and mobile phase was a mixture of
phosphate buffer pH 3.5 and acetonitrile in the ratio of 50:50.
Sample (10 ml) was injected at the ﬂow rate of 1 ml/min and
detected at a wavelength of 254 nm. Indomethacin was used as an
internal standard. The concentration of ketoprofen plotted against
ketoprofen to indomethacin peak area ratio was found to be liner.
2.8. Statistical analysis
Statistical analysis of the experimental results was performed
by ANOVA. Differences were considered statistically signiﬁcant at
po0.05. All the data values are represented as mean7standard
deviation of 3 measurements. Moreover, the in vitro dissolution
data were also compared using a model independent analysis
involving determination of similarity factor f2, which is a measure
of similarity in two drug release proﬁles. The following formula-
tion has been used to calculate the similarity factor [17]:
f 2 ¼ 50log 1þ
1
n
 Xn
t ¼ 1
wtðRtTtÞ2
" #0:5
 100
8<
:
9=
;
where n is number of sample points, Rt and Tt are percentage drug
release at time t from the reference and test products, respectively.3. Results and discussion
3.1. Preparation of the vesicular system
Ethosomes are a vesicular system with hydrated bilayers. The
preparation method involved addition of water at a controlled
rate in the alcoholic solution of lipid and drug. Alcohol is an
essential component of the ethosomal system which is believed
to be responsible for increased transdermal permeability. To
minimize evaporation of alcohol during preparation of etho-
somes, the glass bottle containing alcoholic solution of lipid and
drug was sealed and water was added through Teﬂon tubing
connected to a syringe. Once prepared, formulations were stored
in tightly closed containers to further reduce the chances of
evaporation of ethanol. Optimization of formulations was done
by varying the two process parameters i.e. amount of SPC and
Fig. 3. Three dimensional surface plot showing effect of ethanol and SPC on
average vesicle size of various formulations.
Fig. 4. Three dimensional surface plot showing effect of ethanol and SPC on
entrapment efﬁciency of various formulations.
M.K. Chourasia et al. / Results in Pharma Sciences 1 (2011) 60–67 63alcohol. Amount of SPC was varied from 1% to 3% whereas alcohol
concentration was varied from 20% to 40%. Different formulations
with varying concentrations of SPC and alcohol were character-
ized for appropriate physicochemical attributes.
3.2. Characterization of formulations
It is seen from TEM photomicrograph that ethosomal vesicles are
unilamellar in nature with near spherical shape (Fig. 2 inset). In
contrast to the liposome vesicles that exhibit spherical shapes,
ethosomal vesicles are showing some deviation in terms of shape,
which could be due to absence of cholesterol and presence of
ethanol that imparts some level of ﬂuidity to the bilayer membrane.
Vesicle size plays an important role in the overall performance
of transdermal drug delivery system. Size analysis of the formula-
tions showed that minimum vesicle size was observed to be
120.376.1 nm whereas maximum was 410.2721.8 nm depend-
ing on the concentration of SPC and ethanol (Fig. 2). A surface plot
was prepared to check the effect of both ethanol concentration
and SPC concentration together on vesicle size. A zone of lowest
vesicle size having a size range from 100–143 nm is clearly seen
in Fig. 3. This particular zone is formed with formulations having
1–2% of SPC and 35–40% of alcohol. However the lowest size is
obtained with 1% of SPC and 40% of alcohol. A zone with the
highest size range of 362.5–406.3 nm is formed with 2.5–3% of
SPC and 20–25% of alcohol. The size of the vesicles was found to
be increased with increasing concentrations of SPC from 1–3%
whereas concentration of alcohol affected the vesicle size in the
opposite way i.e. higher concentrations of alcohol produced lower
vesicle size. It has been reported that high concentration of
ethanol confers a surface negative net charge to the vesicular
systems by manipulating some surface characteristics, which
causes the size of vesicles to decrease [13]. When the amount of
SPC was kept at 1% and the concentration of ethanol was
increased from 20% to 40%, the size of the vesicles decreased
from 212.478.3 to 120.376.1 nm (Fig. 2). Similarly when the
amount of SPC was kept at 2% and 3% and the ethanol concentra-
tion was increased in the same manner the vesicle size was
decreased from 295.1714.2 to 147.878.3 nm and 410.2721.8
to 201.2711.2 nm, respectively (Fig. 2).
Encapsulation efﬁciency is the fraction of total drug entrapped
in the ethosomal system. It is an important parameter to evaluateFig. 2. Average vesicle size of various formulations. Values represent mean7SD
(n¼3). Inset ﬁgure shows transmission electron photomicrograph of ethosomes.
E1, E2, E3, y, E9 represent the formulations.as it determines drug holding capacity and ultimately the delivery
potential of dosage form. Zones of different entrapment efﬁcien-
cies with reference to the concentrations of SPC and ethanol can
be identiﬁed from the three dimensional surface plot (Fig. 4). Both
the amount of SPC and ethanol inﬂuenced the entrapment of
ketoprofen inside lipid vesicles in a positive way. A zone with
entrapment efﬁciency of 75–80% is formed with formulations
comprising of 30–40% alcohol and 2.5–3% SPC whereas in terms
of lower efﬁciency, it is formed with compositions of 20–25%
alcohol and 1–2% SPC. Higher entrapment efﬁciency with
increased amount of SPC is on expected line. Hydrophilic drugs
are entrapped in the aqueous core inside lipid carrier while
lipophilic drugs are retained in the nonpolar chain. Encapsulation
of hydrophilic drug depends on captured volume i.e. volume of
water encapsulated per mole lipid whereas entrapment of lipo-
philic drug depends on bilayers present in the system. Being a
hydrophobic drug ketoprofen is expected to entrap in the non-
polar lipid bilayers and as the amount of SPC increased in
formulation the number of bilayers and drug holding capacity
would increase. Entrapment efﬁciency of the formulation com-
posed of 1% SPC and 20% alcohol (E1) was found to be 42.973.7%,
which increased to 63.175.8% when the amount of SPC was
increased to 3% keeping the concentration of alcohol unchanged
Fig. 5. Percent entrapment efﬁciency of various ethosomal formulations. Values
represent mean7SD (n¼3). E1, E2, E3, y, E9 represent formulations. Fig. 6. Percent cumulative drug release after 24 h from various ethosomal
formulations. Values represent mean7SD (n¼3).
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observed to increase with increasing alcohol concentrations.
Ethosomal formulation fabricated with 3% SPC and 20% alcohol
(E7) exhibited 63.175.8% entrapment efﬁciency, which was
increased to 73.772.9% and 78.774.9% when the concentration
of alcohol was increased to 30% and 40%, respectively, keeping the
amount of SPC unchanged at 3%. Higher entrapment efﬁciency
with increased amount of ethanol is possibly due to increased
solubility of drug in ethanol present in the ethosomal core (Fig. 5).3.3. In vitro drug release through cellophane membrane
Cellophane membrane with molecular weight cut off around
12,000 was used for the experiments that retains lipid vesicle and
only permits transfer of drug in solution form. The diffusion of
entrapped drug molecules form the vesicular system is governed
by transfer of drug from vesicles to the surrounding aqueous
medium and then diffusion through the cellophane membrane
into the receptor medium. In case of hydroalcoholic drug solution
most of the drug was released in 2–3 h whereas signiﬁcantly less
(po0.05) amount of drug was released from ethosomal formula-
tions indicating that the diffusion of drug from ethosomal bilayers
is the rate limiting step in overall drug permeation through the
cellophane membrane. The similarity factor (f2) of release proﬁles
of different formulations for various time intervals was deter-
mined in comparison to hydroalcoholic solution. The value of the
similarity factor for all the formulations was found to be less than
50 in comparison to hydroalcoholic drug solution indicating
signiﬁcant difference. Release of the drug was reduced with
increasing amount of SPC in formulation whereas increasing the
concentration of alcohol somewhat increases the drug release.
The formulation composed of 1% SPC and 20% (E1) alcohol
released 81.475% ketoprofen after 24 h whereas increasing the
amount of SPC to 3% resulted in reduced drug release to
71.374.6%, however the difference was found to be insigniﬁcant
(f2450; Fig. 6). The observed increase of drug release with higher
amount of alcohol could be due to increased ﬂuidity of the bilayer
membrane with increasing concentration of alcohol.To assess the release rate kinetic value, values of diffusional
release exponent was calculated by plotting log cumulative
amount of drug release versus log time (graph not shown).
Formulations exhibited diffusional release exponent in the range
of 0.7093–0.7414 indicating non-Fickian release of drug from the
vesicular system. Overall with in vitro release through cellophane
membrane it can be summed up that all the formulations showed
sustained behavior compared to hydroalcoholic drug solution.
3.4. In vitro permeation of drug through skin
The permeation proﬁle of various formulations through the
skin was compared with that obtained from hydroalcoholic drug
solution. The cumulative amount of drug permeated from various
ethosomal formulations was found to be signiﬁcantly higher
(po0.05) in comparison to permeation from hydroalcoholic drug
solution. The value of f2 for all the formulations was found to be less
than 50 in comparison to hydroalcoholic drug solution indicating
signiﬁcant difference. Values of steady state transdermal ﬂux were
calculated from the graph of cumulative drug permeated versus
time and are shown in Table 1. Enhancement ratio was calculated by
dividing transdermal ﬂux of ethosomal formulations to that of
control. Transdermal ﬂux from various ethosomal formulations across
skin was ranged between 165.7719 to 207.1723.3 mg/cm2/h
whereas lower transdermal ﬂux 94.6710.3 mg/cm2/h was
observed with hydroalcoholic drug solution (Table 1). Three
dimensional surface plot was prepared to check the inﬂuence of
composition of ingredients of formulation i.e. SPC and alcohol on
transdermal ﬂux (Fig. 7). It is clear from the surface plot and
Fig. 8 that the highest transdermal ﬂux is observed with a
ethosomal formulation having 1% SPC and 40% ethanol (E3). The
concentration of alcohol has more inﬂuence on transdermal ﬂux
compared to the amount of SPC. Two zones of higher transdermal
ﬂux (198.8–240.4 and 204.4–210 mg/cm2/h) are seen with for-
mulations having 1–1.75% of SPC and 35–40% of alcohol. However
when the concentration of alcohol is decreased to 20–25% with
around the same amount of SPC (1.25–2.25%), the zone with
lowest transdermal ﬂux is reached. Formulation E1, which is
composed of 1% SPC and 20% alcohol showed permeation of
Fig. 7. Three dimensional surface plot showing effect of ethanol and SPC on
transdermal ﬂux of various formulations.
Fig. 8. In vitro permeation of ketoprofen from various formulations through
0.785 cm2 area of human skin. Values represent mean7SD (n¼3).
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to 3529.5759.1 and 3840725.2 mg when the concentration of
alcohol was increased to 30% and 40% respectively (f2o50)
(Fig. 8). Formulation E3, which was composed of the lowest
vesicle size, outperformed all other formulations and showed
the highest transdermal ﬂux. Some other lipid based formulations
are reported in the literature and comparative analysis of skin
permeation can bring a real picture about the performance of
ethosomal formulations. Valenta et al. [36] have prepared soya–
lecithin aggregates (SLA) bearing ketoprofen as model drug and
incorporated these aggregates into hydrophilic and hydrophobic
vehicles and studied the permeation using excised rat skin. The
permeation rates of SLA incorporated into hydrophilic vehicles
like propyleneglycol, polyethyleneglycol 400 and alkyl polyglu-
cosid were found to be approximately 2700–2900 mg through anarea of 1 cm2 in 24 h. Ketoprofen released from hydrophobic
creams was very low and after 24 h, around 300 mg of drug was
released. Permeation from the supersaturated systems based on
SLA–PEG was fairly good and released 2200–3000 mg through an
area of 1 cm2 of rat skin. Comparing their results with ethosomal
formulations, it is clear that skin permeation of ethosomal
formulations is better than soya–lecithin aggregates. The highest
skin permeation with SLA after 24 h, is approximately 2900 mg
through an area of 1 cm2 of rat skin, whereas with ethosomes it is
approximately 3840 mg through an area of 0.785 cm2 of human
skin. Maestrelli et al. [25] prepared b–cyclodextrin (bCyd) and
hydroxypropyl–bCyd (HPbCyd) complexes with ketoprofen and
incorporated them into multilamellar liposomes for topical deliv-
ery. Permeability studies of drug and drug–Cyd complexes, in the
form of suspensions or incorporated in liposomes were performed
both across artiﬁcial membranes and rat skin. Skin permeation
rates of suspension forms were surprisingly higher in comparison
to liposomes. Drug suspensions having ketoprofen exhibited skin
permeation of approximately 670 mg in 24 h compared to 630 mg
in case of lipsosomes bearing ketoprofen. Similar trends were
observed with drug–bCyd and drug–HPbCyd complexes and their
liposomes. Permeation of ketoprofen through skin of all the
formulations is substantially lower compared to ethosomal
formulations.
Predicted in vivo drug plasma concentration was estimated
assuming drug in a patch of 50 cm2. Actually plasma ketoprofen
concentration above 1 mg/ml is reported to elicit analgesic effect
[33] and in order to achieve steady state plasma concentration
above 1 mg/ml the ethosomal preparation is to be fabricated in a
patch size of 50 cm2. However by increasing the amount of drug
in the formulation, the patch size to achieve the same concentra-
tion can be reduced. Steady state plasma concentration from all
the formulations was investigated to be in a narrow range varying
from 1.2170.13 to 1.5270.17 mg/ml. However this is not a point
of concern as the values are well above 1 mg/ml, which is
sufﬁcient to generate therapeutic response in contrast to hydro-
alcoholic drug solution that remained in sub therapeutic range
using a patch of 50 cm2. Highest transdermal ﬂux and conse-
quently highest Pss (1.5270.17 mg/ml) was observed with for-
mulation E3 whereas lowest Pss of 1.2170.13 mg/ml was
observed with E4 (Table 1). Prediction of steady state in vivo drug
plasma concentration was based on assumption that drug were in
a patch of 50 cm2.
To check the kinetics of in vitro permeation, the diffusional
release exponent was calculated. Diffusional release exponent was
estimated as slope of the graph plotted between log cumulative
amounts of drug release versus log time (graph not shown). The
diffusional release exponent is a parameter that is indicative of drug
release mechanism. A diffusional release exponent of 0.5 indicates
normal concentration-controlled Fickian diffusion (case I). Exponent
of 1 indicates zero order release (case II) while its value more than
1 indicates super case II type release. The value of diffusional release
exponent for all the formulations was found to be around one which
indicates that absorption of drugs through the skin follows zero
order release. Systems that obey zero order release are ideal for
transdermal drug delivery as they provide constant release of drug
over an extended period of time and reﬂect improved therapeutic
index. The kinetics of ketoprofen across skin (zero order) is different
from that across cellophane membrane (non-Fickian). This may be
due to the fact that skin has complex structure and release proﬁle of
drugs from delivery system through skin cannot be exactly matched
with cellophane membrane. It may suggest that other than the
ethosome itself, skin also modiﬁed the diffusion properties of
ketoprofen. This can be explained in a way that some component
of the skin might be interacting with the ethosomes and altering its
diffusional properties.
Fig. 9. Confocal microscopy showing penetration of ﬂuorescent probe Rhodamine
123 into human skin. (A) Penetration of Rhodamine 123 entrapped in ethosomes
and (B) shows penetration of ﬂuorescent probe from hydroalcoholic solution.
(C) Fluorescent intensity of Rhodamine 123 into human skin. Thumbnails 1–6,
7–12, 13–18 and 19–24 show the depth of skin penetration of 0–10, 10–20, 20–30
and 30–40 mm, respectively.
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tions is concordant with the reports published in literature
showing enhanced drug permeation with lipid vesicles having
ethanol as one of components [4,8,27,37]. Alcohol is a natural
enhancer, which has the property to alter the skin permeability.
However transdermal permeability of ethosomal formulations
was found to be higher compared to hydroalcoholic drug solution
which indicates that it is not alcohol alone which is contributing
for higher skin permeability. Several studies have investigated the
possible mechanism for improved skin permeability with lipid
vesicular system. Vesicles can act as a carrier of drug and intact
vesicles penetrate the stratum corneum along with the encapsu-
lated drug. Secondly vesicles can act as penetration enhancer and
interacts with the stratum corneum lipids and alter the perme-
ability, which facilitates penetration of drug molecule across
stratum corneum. Enhanced permeation of drug with ethosomal
formulations could be due to combined effect of alcohol and lipid
vesicular system. Skin is a densely packed organ and lipids are
arranged in a symmetric conformation. Alcohol being a penetra-
tion enhancer might interact with the skin lipid and disturbs its
conformation with consequent increase in ﬂuidity. Exploiting
increased ﬂuidity of skin lipids, ethosomes, which are ﬂexible in
nature, intermingles with the skin lipid and penetrate across
disordered stratum corneum. Once it penetrates the stratum
corneum the release of drug depends on further interaction of
formulation with the skin lipids.
3.5. Confocal laser scanning microscopy
To visualize the permeation modes of the ethosomes through
stratum corneum, they were further investigated by using con-
focal laser scanning microscopy. Penetration through stratum
corneum is the rate limiting step in the overall transdermal
delivery of drugs or other delivery vehicle. Once the drug or
formulation crosses stratum corneum its further penetration or
absorption is relatively easy. Fig. 9A and B shows the penetration
of Rhodamine 123 from ethosomal vesicles and hydroalcoholic
probe solution, respectively. Figures are divided in four parts
showing penetration of Rhodamine 123 at different depth levels
through the skin. It is clear from the confocal photomicrographs
that intensity of ﬂuorescent probe Rhodamine 123 is much higher
from ethosomal formulation in comparison to hydroalcoholic
drug solution containing the same concentration of alcohol. The
greater ﬂuorescent intensity with ethosomal system compared to
hydroalcoholic drug solution further conﬁrms that alcohol is not
the only driving force promoting penetration across skin. It is
clear from the confocal photomicrograph (Fig. 9A) that ﬂuores-
cence of Rhodamine 123 is visible in outer region of the lipid
vesicles indicating entrapment of probe in hydrophobic chain of
the lipid bilayer. It is interesting to note the presence of de-
shaped vesicles penetrating through the skin, which suggest that
intact vesicles can penetrate stratum corneum with drug release
taking place afterwards. Quantitative estimation of ﬂuorescent
intensity was performed and is represented as graph in Fig. 9C.
Depth of penetration of dye across skin was divided in four parts
i.e. 0–10, 10–20, 20–30 and 30–40 mm and average ﬂuorescent
intensity in each block was estimated using the software Image-J
[15]. It is clear from the graphs that ﬂuorescent intensity of
ethosomal entrapped dye is substantially higher in comparison to
its hydroalcoholic solution. Fluorescent intensity of Rhodamine
123 entrapped in lipid vesicles was calculated to be 15.373.3 at
30–40 mm inside skin whereas with hydroalcoholic solution it
was 5.772.8. In terms of skin penetration, both qualitative and
quantitative data revealed excellent performance of ethosomes
entrapped Rhodamine 123 compared to hydroalcoholic solution.
However, cautions should be taken when these results arecompared with those of ketoprofen since the Log P of Rhodamine
123 is 1.2, while the Log P of ketoprofen is 0.97 [3].4. Conclusions
It can be concluded from the results of the study that
ethosomal formulation is a potentially useful vehicle for trans-
dermal delivery of ketoprofen. Vesicles with appropriate size and
reasonable entrapment efﬁciency can be prepared. Results of the
in vitro release study through the skin revealed higher transder-
mal ﬂux with ethosomal formulation compared to hydroalcoholic
drug solution. Confocal laser scanning microscopy further con-
ﬁrmed the potential of ethosomal system by showing high
ﬂuorescent intensity of Rhodamine 123 loaded formulation com-
pared to hydroalcoholic solution of probe across skin.Acknowledgments
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